Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2025-11-25
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard consent forms
The approved standard consent form will be used during the consent processes.
Standard Consent Form
The IRB-approved consent form will be used by research team staff during consenting process of participants for parent studies.
Standard consent forms with a visual key information (VKI) page
The approved standard consent form with a VKI page will be used during the consent processes.
Standard Consent Form
The IRB-approved consent form will be used by research team staff during consenting process of participants for parent studies.
Visual Key Information (VKI) page
A VKI page will be designed for each parent study based on study materials and current consent document. The VKI will be implemented in the consent material for the study.
Research Team Members
Members of the parent study's research team will complete the research team survey to assess opinions on consent process.
Standard Consent Form
The IRB-approved consent form will be used by research team staff during consenting process of participants for parent studies.
Visual Key Information (VKI) page
A VKI page will be designed for each parent study based on study materials and current consent document. The VKI will be implemented in the consent material for the study.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Standard Consent Form
The IRB-approved consent form will be used by research team staff during consenting process of participants for parent studies.
Visual Key Information (VKI) page
A VKI page will be designed for each parent study based on study materials and current consent document. The VKI will be implemented in the consent material for the study.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient must be 18 years or older
* Patients must be English-speaking
* Able to understand an IRB-approved written consent document
* Must go through the consent process for one of the parent studies
Research Team Eligibility Criteria:
* Member of a parent study research team
* Engaged in the study consent processes, including creating and reviewing consents or enrolling participants
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Washington University School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mary C Politi, PhD
Role: PRINCIPAL_INVESTIGATOR
Washington University in St. Louis School of Public Health
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
202511065
Identifier Type: -
Identifier Source: org_study_id